Assistant Professor Eric Lock is developing a method that will allow researchers to analyze different kinds of cancer and molecular cell data together.
Associate Professor Pamela Lutsey found that DOAC drugs appear to be just as safe to use as heparin and warfarin for treating venous thromboembolism in cancer patients.
The method developed by Assistant Professor Silvia Balbo may help researchers uncover the genetic chemistry leading to cancer development, which has broad applications ranging from understanding how toxins are affecting DNA in the body to developing tools to improve outcomes of chemotherapy.
Research by PhD student Mary Rooney links serious health risks to dichlorophenols, a chemical commonly found in a variety of products including chlorinated drinking water.
Researcher and Associate Professor Irina Stepanov found that while e-cigarettes contain virtually no N-nitrosonornicotine (NNN) — a chemical that can cause oral cavity and esophageal cancer — the chemical can form in an e-cigarette user’s body when they take in nicotine through e-cigarettes.
Research from graduates Uzoma Abakporo (MPH, ‘15) and Abdirahman Hussein (MPH, ’15) examines the role of men in helping to raise HPV vaccination and cervical cancer screening rates in local Somali women and children.
Assistant Professor Silvia Balbo is on the American Society of Mass Spectrometry’s 2017 list of emerging investigators for her work searching for the causes of cancer rooted in human DNA.
A new study from alumna Shuling Li (PhD, ‘13) shows how chemo side-effects could cause kidney damage in elderly breast cancer patients.